Bonus Material-05_2025 EosinophilicLevine

Pdf Summary

This comprehensive review by Dr. Stephanie M. Levine covers eosinophilic lung diseases, a group of disorders marked by increased eosinophils in lung tissues and/or blood, causing radiographic abnormalities and impaired lung function. These diseases range from primary lung-limited types like Acute Eosinophilic Pneumonia (AEP) and Chronic Eosinophilic Pneumonia (CEP), to systemic conditions such as Hypereosinophilic Syndrome (HES) and Eosinophilic Granulomatosis with Polyangiitis (EGPA or Churg-Strauss Syndrome). Secondary eosinophilic disorders arise from infections, allergens, drugs, or malignancies.

Key cytokines include IL-5, which specifically stimulates eosinophil growth. Eosinophils release toxic granules like major basic protein, contributing to tissue damage or immune response.

Distinct disorders were discussed:  
- <strong>AEP</strong> presents acutely with hypoxemia and diffuse lung opacities, often linked to new smoking or drug exposures such as daptomycin; peripheral eosinophilia is often absent early, but BAL shows marked eosinophilia.  
- <strong>CEP</strong> affects middle-aged non-smokers with asthma and presents subacutely with peripheral blood eosinophilia and characteristic peripheral lung infiltrates. Relapses are common after corticosteroid treatment.  
- <strong>ABPA</strong> is a hypersensitivity reaction to Aspergillus in asthmatics or cystic fibrosis patients, diagnosed by elevated IgE, eosinophilia, and radiographic findings like mucoid impaction and bronchiectasis.  
- <strong>EGPA</strong> is a systemic necrotizing eosinophilic vasculitis characterized by asthma, eosinophilia, sinus disease, neuropathy, and variable ANCA positivity. Treatment depends on severity and includes corticosteroids, cytotoxic agents, and biologics like mepolizumab.  
- <strong>HES</strong> involves persistent unexplained eosinophilia and multi-organ involvement, treated with corticosteroids and targeted therapies.

Parasitic infections (e.g., strongyloidiasis, Loeffler syndrome), drug-induced eosinophilic pneumonia, and other rare causes were also detailed. Diagnosis relies on clinical presentation, lab markers (blood and BAL eosinophilia, IgE), imaging, and exclusion of infections. Most eosinophilic lung diseases respond well to corticosteroids, though some require additional immunomodulatory therapies.

In summary, understanding the clinical patterns, diagnostic criteria, and treatments of eosinophilic lung disorders is essential for proper management and improved patient outcomes.

Meta Tag

Concept Eosinophilic Pulmonary Disorder

Concept Acute Eosinophilic Pneumonia

Concept Chronic Eosinophilic Pneumonia

Concept Allergic Bronchopulmonary Aspergillosis

Concept Eosinophilic Granulomatosis with Polyangiitis

Keywords

eosinophilic lung diseases

acute eosinophilic pneumonia

chronic eosinophilic pneumonia

hypereosinophilic syndrome

eosinophilic granulomatosis with polyangiitis

allergic bronchopulmonary aspergillosis

eosinophilia

corticosteroid treatment

bronchoalveolar lavage

interleukin-5

Eosinophilic Pulmonary Disorder

Acute Eosinophilic Pneumonia

Chronic Eosinophilic Pneumonia

Allergic Bronchopulmonary Aspergillosis

Eosinophilic Granulomatosis with Polyangiitis